All videos

Nasal Vaccine For Alzheimer’s To Begin First Human Trial

The culmination of 20 years of research, this vaccine could help prevent the disease developing in people most at risk.

Share:
World Economic Forum logo

Forum Stories newsletter

Bringing you weekly curated insights and analysis on the global issues that matter.

Subscribe today

About us

Engage with us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2025 World Economic Forum